by Alison Bass | Aug 13, 2009 | Uncategorized
In recent weeks, researchers with ties to the drug industry have once again tried to drum up opposition to the FDA’s black box warnings on antidepressants for children and young adults. The latest dart came in an Archives of General Psychiatry study in June...
by Alison Bass | Aug 5, 2009 | Uncategorized
At a conference I attended yesterday in Boston on Reinventing Journalism, the talk was all about how online social media tools are introducing new models of sharing information and helping journalists do their jobs better. The panelists made scant reference to the...
by Alison Bass | Jul 24, 2009 | Uncategorized
Since Congress isn’t going to pass a health care reform bill any time soon, this looks like a good time to take some vacation. I will resume blogging the week of August 3. Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new...
by Alison Bass | Jul 21, 2009 | Uncategorized
In response to my blog on Frances Collins last week, a reader pointed out that the kind of data image manipulation that Collins belatedly discovered in his own lab is more common than many scientists would like to admit: as much as 25 percent of scientific papers...
by Alison Bass | Jul 13, 2009 | Uncategorized
When the news broke last week that President Obama had selected Francis Collins to be the new director of the National Institutes of Health, I didn’t immediately think of this noted geneticist in connection with a case study in ethics that a visiting scientist...
by Alison Bass | Jul 8, 2009 | Uncategorized
Just yesterday, Senators Charles Grassley and Herbert Kohl announced that language requiring the public disclosure of payments to doctors from drug and medical device companies has been included in the draft bills for health care reform now being debated in the House...
